Universe Pharmaceuticals
General Information | |
Business: | We are a pharmaceutical company based in Jiangxi, China, specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (“TCMD”) products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. We have registered and obtained approval for 26 varieties of TCMD products from the National Medical Products Administration (the “NMPA”), and we currently produce 13 varieties of TCMD products, which are sold in approximately 261 cities of 30 provinces in China as of the date of this prospectus. In addition, through our subsidiary Jiangxi Universe Pharmaceuticals Commercial Trade Co., Ltd. (“Universe Trade”), we sell not only our own TCMD products, but also biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (“TCMPs”), and dietary supplements manufactured by third-party pharmaceutical companies.
|
Industry: | Pharmaceuticals |
Employees: | 56 |
Founded: | 1998 |
Contact Information | |
Address | 265 Jingjiu Avenue Jinggangshan Economic and Technological Development Zone Ji’an, Jiangxi, China 343100 |
Phone Number | +86-0796-8403309 |
Web Address | http://www.dzrzy.com |
View Prospectus: | Universe Pharmaceuticals |
Financial Information | |
Market Cap | $126mil |
Revenues | $30.7 mil (last 12 months) |
Net Income | $8.4 mil (last 12 months) |
IPO Profile | |
Symbol | UPC |
Exchange | NASDAQ |
Shares (millions): | 5.0 |
Price range | $5.00 - $5.00 |
Est. $ Volume | $25.0 mil |
Manager / Joint Managers | Univest Securities |
CO-Managers | - |
Expected To Trade: | 3/23/2021 |
Status: | Priced |
Quiet Period Expiration Date: | Available only to Subscribers |
Lock-Up Period Expiration Date: | Available only to Subscribers |
SCOOP Rating | Available only to Subscribers |
Rating Change | Available only to Subscribers |